This educational supplement is sponsored by Medtronic.
In this supplement:
- Spotlight on the OsteoCool RF ablation system
- Watching a “small Canadian invention” transform cancer care: Insights from an OsteoCool pioneer
- “Compelling” OPuS One trial results confirm the role of percutaneous ablation in musculoskeletal metastases
- Case report: Treating expansile L1 breast cancer metastases with the OsteoCool RF ablation system